Ross Leimberg is a Director at AbbVie Ventures, and for the past 6 years he has been focused on identifying and executing equity investments in companies focused on generated therapeutics within the areas of oncology, immunology, and neurodegeneration. He draws from business development, investing, and consulting experiences from within the life sciences industry. Prior to joining AbbVie, Ross was an Entrepreneur-in-Residence at Harvard, where he drove company creation activities across a portfolio of Harvard technologies. Previously, Ross worked in Pfizer’s business development and commercial planning groups, and he began his career at ZS Associates as a pharmaceutical consultant.
Ross is attending / has attended: